Skip to main content
. 2016 Apr 5;8(4):659–671. doi: 10.1080/19420862.2016.1156829

Table 3.

Grade 3/4 toxicities reported for SN-38 ADCs & irinotecan.

  Irinotecan monotherapy Labetuzumab govitecan Sacituzumab govitecan
Dosing regimen once weekly 125 mg/m2 Once weekly 10 mg/kg or twice weekly 6 mg/kg days 1 and 8 of 21 day cycle 10 mg/kg
Neutropenia 26% 10% 24%
Febrile neutropenia 3%   6%
Diarrhea 31% 2% 3%
Leukopenia 28%   2%
Anemia 7% 3% 6%